LIPOCINE INC. Deferred Tax Assets, Operating Loss Carryforwards, State and Local
LIPOCINE INC. (LPCN) had Deferred Tax Assets, Operating Loss Carryforwards, State and Local of $40.75 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $40.75M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $34.28M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $35.11M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, State and Local $35.60M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, State and Local |
|---|---|
| 2025-12-31 | $40.75M 10-K · filed 2026-03-10 |
| 2024-12-31 | $34.28M 10-K · filed 2026-03-10 |
| 2023-12-31 | $35.11M 10-K · filed 2025-03-13 |
| 2022-12-31 | $35.60M 10-K · filed 2024-03-07 |
| 2021-12-31 | $34.76M 10-K · filed 2023-03-10 |
| 2020-12-31 | $35.10M 10-K · filed 2022-03-09 |
| 2019-12-31 | $30.57M 10-K · filed 2021-03-11 |
| 2018-12-31 | $27.40M 10-K · filed 2020-03-13 |
| 2017-12-31 | $25.40M 10-K · filed 2019-03-06 |
| 2016-12-31 | $30.70M 10-K · filed 2018-03-12 |
| 2015-12-31 | $23.68M 10-K · filed 2017-03-06 |
| 2014-12-31 | $17.48M 10-K · filed 2016-03-10 |
| 2013-12-31 | $10.04M 10-K · filed 2015-03-11 |
| 2012-12-31 | $9.22M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |